Similar articles

• Editorial: Malignant hyperthermia: a pharmacogenetic disease of skeletal and cardiac muscle.

  Britt BA. Britt BA. N Engl J Med. 1974 May 16;290(20):1140-2. doi: 10.1056/NEJM197405162902012. N Engl J Med. 1974. PMID: 4274465 No abstract available.
• [New aspects in the clinical picture of malignant hyperthermia (author's transl)].

  Junger H, Kuhnle P, Schorer R. Junger H, et al. Z Kinderchir Grenzgeb. 1980 May;30(1):35-7. Z Kinderchir Grenzgeb. 1980. PMID: 7456684 German.
• [Malignant hyperthermia: case-finding of subjects at risk].

  Viering WA, Sengers RC, Stadhouders AM, Gielen MJ, Festen C. Viering WA, et al. Ned Tijdschr Geneeskd. 1986 May 31;130(22):1002-4. Ned Tijdschr Geneeskd. 1986. PMID: 3724881 Dutch. No abstract available.
• [Malignant hyperthermia].

  Nalda MA, González-Machado JL. Nalda MA, et al. Med Clin (Barc). 1985 Jan 19;84(2):74-7. Med Clin (Barc). 1985. PMID: 2983154 Review. Spanish. No abstract available.
• [Etiology of malignant hyperthermia].

  Okumura F, Kuro M. Okumura F, et al. Masui. 1975 Jun;24(6):525-37. Masui. 1975. PMID: 169408 Review. Japanese. No abstract available.